Cardiometabolic Index as a predictor of mortality in metabolic Dysfunction-Associated Steatotic Liver Disease
Abstract Background Cardiometabolic Index (CMI) is positively correlated with liver fibrosis in patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), but its association with mortality risk in MASLD patients remains unclear. Methods This study utilized data from NHANES III...
Saved in:
| Main Authors: | Yang Yang, Cheng Zeng, Zhiqiang Jin, Yi Huang, Huabao Liu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | BMC Gastroenterology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12876-025-04127-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cardiometabolic risk in non-diabetic metabolic dysfunction-associated steatotic liver disease (MAFLD) patients: insights from the triglyceride-glucose, plasma atherogenic, and cardiometabolic index
by: Sedat Ciftel, et al.
Published: (2024-07-01) -
Association of dietary inflammatory index on all-cause and cardiovascular mortality in U.S. adults with metabolic dysfunction associated steatotic liver disease
by: Lin Tao, et al.
Published: (2025-04-01) -
Association of triglyceride-glucose index with all-cause and non-cardiovascular mortality in patients with obstructive sleep apnea: an age-stratified analysis
by: Xiao Hu, et al.
Published: (2025-07-01) -
Triglyceride-glucose index as an independent predictor of mortality in patients with chronic respiratory diseases
by: Hongyu Lu, et al.
Published: (2025-05-01) -
Associations between cardiometabolic indices and the onset of metabolic dysfunction-associated steatotic liver disease as well as its progression to liver fibrosis: a cohort study
by: Ziping Song, et al.
Published: (2025-04-01)